A mobile-based randomized controlled trial on the feasibility and effectiveness of screening for major depressive disorder: study protocol
2024

Mobile Screening for Depression Study Protocol

Sample size: 1786 publication Evidence: moderate

Author Information

Author(s): Zandbergen M. M. E., Jansen E. E. L., Jabbarian L. J., de Koning H. J., de Kok I. M. C. M.

Primary Institution: Erasmus MC, University Medical Center Rotterdam

Hypothesis

A mobile-based screening strategy for MDD will substantially reduce the burden of MDD over time, improve participants’ QoL, and minimize disparities associated with MDD.

Conclusion

The study aims to evaluate the feasibility and effectiveness of mobile-based screening for major depressive disorder in a diverse population.

Supporting Evidence

  • Mobile-based screening tools can enhance accessibility and improve mental health outcomes.
  • Screening for depression is recommended in several healthcare settings.
  • Previous studies suggest that screening may effectively reduce MDD symptoms.

Takeaway

This study is trying to see if using a phone app to check for depression can help people feel better and get the help they need.

Methodology

A three-arm, parallel randomized controlled trial with two intervention groups screened for MDD using the PHQ-9 questionnaire and a control group.

Potential Biases

Participants may self-select into the study, which could introduce bias.

Limitations

Potential dropout rates and challenges in recruiting the target population within the specified time frame.

Participant Demographics

The study targets a multi-ethnic population in Rotterdam, with over 90% having origins outside of Dutch heritage.

Digital Object Identifier (DOI)

10.1186/s40359-024-02230-6

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication